Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+8.74%
EPS
−100.0%
Free cash flow
−0.54%
Total debt
−0.55%

Quarter to June 2026, against a year earlier

76.45 0.86 −1.11%
Market cap
$36.9B
P/E
58.4×
Fwd P/E
44.5×
Dividend yield
0.46%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100

Alcon (ALC) Operating cash flow

Alert me on Operating cash flow

Alcon's operating cash flow for fiscal 2025 was $2.3B, up 9.34% from $2.1B in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.3B. Over the past ten years it has ranged from $823.0M (fiscal 2020) to $2.3B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Alcon ranks 4th of 51 Medical Instruments & Supplies companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $2.3B 9.34%
FY2024 $2.1B 49.64%
FY2023 $1.4B 14.05%
FY2022 $1.2B (9.52%)
FY2021 $1.3B 63.43%
FY2020 $823.0M (10.54%)
FY2019 $920.0M (19.30%)
FY2018 $1.1B (6.82%)
FY2017 $1.2B 1.71%
FY2016 $1.2B —

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $510.0M 22.01%
Mar 2026 $418.0M (36.47%)
Dec 2025 $658.0M (9.12%)
Sep 2025 $724.0M 43.37%
29 more quarters

Against its own ten years

Low $823.0M High $2.3B
Ten-year median $1.2B
Current reading's percentile 100

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on ALC